Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
about
Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesisGalectin-1 research in T cell immunity: past, present and futureVon Willebrand factor, angiodysplasia and angiogenesisRegulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatmentGalectins in epithelial functionsGalectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac CellsIdentification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotionStructural Basis for Galectin-1-dependent Pre-B Cell Receptor (Pre-BCR) ActivationThe Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaBlocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growthGalectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infectionRas inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosisGalectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myelomaProteomic analyses of the Xiphophorus Gordon-Kosswig melanoma model.VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.Galectins and gliomas.Galectin-1 and its involvement in hepatocellular carcinoma aggressivenessThe clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGFGalectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.Galectin-1 links tumor hypoxia and radiotherapy.Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.Role of galectins in re-epithelialization of wounds.Glycobiology of ocular angiogenesis.Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.Folding and function in α/β-peptides: targets and therapeutic applications.Proteomic comparison of mcf-7 tumoursphere and monolayer culturesAntitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate bindingEnhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulvenThe anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins.Fingerprinting of galectins in normal, P. aeruginosa-infected, and chemically burned mouse corneasTiming of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosisPancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
P2860
Q24302420-FF9A08C9-207B-4467-9425-ED1AB73F6AA4Q26825120-F64D1CEA-6470-4C14-B841-D7850E575E05Q26852889-7F2812A4-1688-4F6F-A24D-6E5FB99C2836Q26991865-5C05DA06-432F-4830-8F76-A452CF087B56Q27000800-B513191F-7646-45A8-BEF4-B9337D70CD95Q27303934-0FE4BB83-E56F-46AD-A0EF-0CE5991C8856Q27332209-636779B9-853A-4C84-9AEA-AC8E385D663DQ27674972-EEC22F4E-622E-48AF-AFBC-7A2344CD2A68Q28075523-47960CB9-1E22-4ABE-8AC8-8CAED9E5A2F6Q28081459-BC825232-1330-45C0-A10A-ED884E3A7B25Q28116133-E08696DE-7C42-4B3D-8B23-A7D703852500Q28252518-91157BBE-F2A7-41A5-A403-DBFF5A0A39FFQ28287799-77730F6A-30F4-4505-BE3F-1ABC75CC6ABBQ28742668-6FA56651-26B9-4EB3-BEEA-A504C765F168Q30423099-1AC53789-6D8E-4A55-868C-6F57849472EEQ31121321-A38EA267-5AC4-45E3-9440-7AE7FBA5511EQ33588438-B46751AA-71BC-4B83-9F39-9FA92B4769F2Q33692511-ADF10210-37F3-4119-818B-50DE76773F61Q33705268-7F98CED9-7279-4370-A809-0C8C1E11F043Q33779141-87BE6B8C-7181-4AC1-B5EE-6B053FFB2930Q33814898-9735A308-7890-4642-A7F0-758930BF0482Q34039409-A7F0261B-2309-4E99-8A7A-BEE622A50C08Q34060270-72938893-A5BA-44C9-B1FA-2645CFA4D13BQ34129297-D1B6503D-2FC7-4809-AA3D-1170FF872248Q34258192-C3009C6B-1B8B-4978-A9AB-B9810D7286B9Q34268364-651A9AC2-37F9-4BEB-BABF-7AF9F47EEBC1Q34385160-344DE902-DF39-47F5-8CC7-18F455833D06Q34414227-EEE613CC-AD93-4D3A-9FB4-17538E600A74Q34438522-453B2E02-0A61-4000-AC61-CFE5FD3EFD5BQ34483276-1E4F07E9-F17F-45DF-A5C3-10837F2AE152Q34534423-0A141118-45E1-49F6-AFF9-62830FDA8F2DQ34564173-B83A74B0-1B12-4A49-A90A-8D749849B845Q34564433-3A923F29-F98F-4451-9633-5F0CAF6BF41DQ34589227-4235D11B-153F-464D-BB0A-ED99D15F4B93Q34799812-99BBD752-8B65-4F83-A24B-7DDD389C046FQ34999835-EBD6BCBB-E2A1-40C1-90A0-955B99278BD8Q35076790-6F253015-2596-4BB9-B57D-6BDEEB340C18Q35085674-C21C90EF-83C8-42FC-BAB3-ADA5DB47D9A4Q35111396-04EF19B4-8138-4560-9F25-6B63FA52C821Q35161285-2F4A9DBD-38E0-4193-87ED-AD7FCBD7C191
P2860
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@ast
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@en
type
label
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@ast
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@en
prefLabel
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@ast
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@en
P2093
P2860
P50
P356
P1476
Galectin-1 is essential in tum ...... t for antiangiogenesis therapy
@en
P2093
Arjan W Griffioen
Françoise Poirier
Kevin H Mayo
Linda G Baum
Nicole Verhofstad
Ricardo J M G E Brandwijk
Ruben Postel
Sietske Satijn
P2860
P304
15975-15980
P356
10.1073/PNAS.0603883103
P407
P577
2006-10-16T00:00:00Z